Roflumilast Tablet
Product Images NDC 59746-801

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Roflumilast (NDC 59746-801). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jubilant Cadista Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30s (30s)

Label for Roflumilast Tablets 500 mcg oral tablets by Jubilant Cadista Pharmaceuticals Inc. The label indicates a 30 tablet count, includes dosage information for adults, storage conditions, and a barcode. It specifies the product is made in the USA and requires dispensing the accompanying medication guide.*

FDA Label Image

90s (90s)

Roflumilast Tablets 500 mcg oral tablet packaging label from Jubilant Cadista Pharmaceuticals Inc. The label states each tablet contains 500 mcg roflumilast and includes dosage instructions for adults. The package contains 90 tablets and indicates prescription use only. The label also lists storage conditions and includes a barcode and marketing information for the manufacturer based in the USA.*

FDA Label Image

Carton (Carton)

Packaging label for Roflumilast Tablets 250 mcg oral tablets by Jubilant Cadista Pharmaceuticals Inc. The carton contains a 28-day supply with 28 tablets (two 14-tablet blister cards). The label includes dosage strength, labeler name, NDC number 59746-801-70, and a note to dispense the accompanying medication guide.*

FDA Label Image

Foil (Foil)

Packaging label for Roflumilast tablets 250 micrograms by Jubilant Cadista Pharmaceuticals Inc. The label features a weekly pill organizer format with sections for each day of the week marked Monday through Sunday. The product is designated Rx only with barcodes, lot number, and expiration date placeholders. Instructions advise not to remove from the blister until immediately prior to administration and specify use during the first 28 days only.*

FDA Label Image

Structure (Structure)

Chemical structure of roflumilast, the active ingredient in Roflumilast oral tablets. The diagram shows the molecular arrangement including aromatic rings, fluorine atoms, and chlorine substitutions characteristic of roflumilast.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.